Tekla Capital Management’s Larimar Therapeutics LRMR Stock Holding History

Tekla Capital Management’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,109	Closed	-$61K	–	192
2017 Q4	$61K	Hold	1,109	–	–	﹤0.01%	160
2017 Q3	$47K	Hold	1,109	–	–	﹤0.01%	152
2017 Q2	$47K	Hold	1,109	–	–	﹤0.01%	143
2017 Q1	$62K	Hold	1,109	–	–	﹤0.01%	138
2016 Q4	$42K	Hold	1,109	–	–	﹤0.01%	142
2016 Q3	$44K	Hold	1,109	–	–	﹤0.01%	141
2016 Q2	$80K	Hold	1,109	–	–	﹤0.01%	155
2016 Q1	$89K	Hold	1,109	–	–	﹤0.01%	139
2015 Q4	$84K	Hold	1,109	–	–	﹤0.01%	132
2015 Q3	$425K	Hold	1,109	–	–	0.02%	157
2015 Q2	$461K	Hold	1,109	–	–	0.02%	112
2015 Q1	$527K	Sell	1,109 -1,109	-50%	-$526K	0.02%	113
2014 Q4	$821K	Buy	+2,218	New	+$572K	0.04%	88

Other funds holding LRMR

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return